BP vs CRGY

BP's Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to its Graham Number ($7.35) and even the growth-based intrinsic value ($18.88), currently priced at $36.53, driven by high forward earnings expectations. While profitability metrics and dividend yield are attractive, elevated valuation multiples, inconsistent earnings surprises, and a dangerously high payout ratio of 315% raise sustainability concerns. Analysts recommend a 'buy' with a target of $38.73, supported by strong insider sentiment, though no insider transactions have occurred recently.

CRGY presents a conflicted profile with a Piotroski F-Score of 4/9, indicating stable but mediocre financial health. While the stock trades below its Graham Number ($13.82), suggesting defensive value, it trades at a significant premium to its growth-based intrinsic value ($3.78). Severe year-over-year EPS contraction (-103.8%) and a dangerously high dividend payout ratio (88.89%) offset the bullish analyst consensus and low forward P/E. The technical trend is currently bearish (10/100), suggesting a loss of momentum despite strong 1-year gains.